Lingyan Lv

941 total citations
22 papers, 749 citations indexed

About

Lingyan Lv is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Lingyan Lv has authored 22 papers receiving a total of 749 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Biomaterials and 5 papers in Biomedical Engineering. Recurrent topics in Lingyan Lv's work include RNA Interference and Gene Delivery (10 papers), Nanoparticle-Based Drug Delivery (8 papers) and Nanoplatforms for cancer theranostics (5 papers). Lingyan Lv is often cited by papers focused on RNA Interference and Gene Delivery (10 papers), Nanoparticle-Based Drug Delivery (8 papers) and Nanoplatforms for cancer theranostics (5 papers). Lingyan Lv collaborates with scholars based in China and United States. Lingyan Lv's co-authors include Hongliang Xin, Wei Lv, Qunwei Xu, Yan Jiang, Yue Zhao, Zhongyuan Wang, Baoyan Wang, Lin Wu, Shengnan Li and Xiuzhen Wang and has published in prestigious journals such as Biomaterials, Scientific Reports and ACS Applied Materials & Interfaces.

In The Last Decade

Lingyan Lv

21 papers receiving 742 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingyan Lv China 16 362 347 260 87 86 22 749
Ann T. Chen United States 13 448 1.2× 279 0.8× 299 1.1× 53 0.6× 98 1.1× 15 812
Chunhui Ruan China 14 349 1.0× 387 1.1× 381 1.5× 55 0.6× 110 1.3× 18 806
Yibin Wang Australia 8 544 1.5× 341 1.0× 428 1.6× 59 0.7× 82 1.0× 9 972
Jianpei Xu China 10 310 0.9× 206 0.6× 252 1.0× 142 1.6× 132 1.5× 15 662
Deyu Miao China 9 443 1.2× 481 1.4× 324 1.2× 38 0.4× 78 0.9× 15 895
Saejeong Kim United States 7 298 0.8× 551 1.6× 510 2.0× 69 0.8× 145 1.7× 10 1.1k
Xingye Feng China 10 378 1.0× 407 1.2× 348 1.3× 26 0.3× 68 0.8× 11 713
Shunping Han United Kingdom 11 285 0.8× 209 0.6× 189 0.7× 27 0.3× 53 0.6× 21 558
L. Tiffany Lyle United States 15 382 1.1× 187 0.5× 203 0.8× 50 0.6× 37 0.4× 21 831
Lisha Liu China 10 313 0.9× 396 1.1× 387 1.5× 48 0.6× 141 1.6× 28 905

Countries citing papers authored by Lingyan Lv

Since Specialization
Citations

This map shows the geographic impact of Lingyan Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingyan Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingyan Lv more than expected).

Fields of papers citing papers by Lingyan Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingyan Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingyan Lv. The network helps show where Lingyan Lv may publish in the future.

Co-authorship network of co-authors of Lingyan Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Lingyan Lv. A scholar is included among the top collaborators of Lingyan Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingyan Lv. Lingyan Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Ye, Lu, Wei Lv, Shengnan Li, et al.. (2023). Reduced malignant glioblastoma recurrence post-resection through the anti-CD47 antibody and Temozolomide co-embedded in-situ hydrogel system. Journal of Controlled Release. 359. 224–233. 16 indexed citations
4.
Zhang, Jiaqing, Qiaoling Ren, Junfeng Chen, et al.. (2022). Downregulation of miR-192 Alleviates Oxidative Stress-Induced Porcine Granulosa Cell Injury by Directly Targeting Acvr2a. Cells. 11(15). 2362–2362. 11 indexed citations
5.
Lv, Wei, et al.. (2022). Advances of nano drug delivery system for the theranostics of ischemic stroke. Journal of Nanobiotechnology. 20(1). 248–248. 41 indexed citations
6.
Wang, Xiaoqi, Lu Ye, Shengnan Li, et al.. (2022). In situ targeting nanoparticles-hydrogel hybrid system for combined chemo-immunotherapy of glioma. Journal of Controlled Release. 345. 786–797. 59 indexed citations
7.
Li, Shengnan, Qí Zhāng, Lu Ye, et al.. (2022). Enhanced treatment of cerebral ischemia–Reperfusion injury by intelligent nanocarriers through the regulation of neurovascular units. Acta Biomaterialia. 147. 314–326. 27 indexed citations
8.
Cao, Xiang, Shengnan Li, Wenli Chen, et al.. (2022). Multifunctional Hybrid Hydrogel System Enhanced the Therapeutic Efficacy of Treatments for Postoperative Glioma. ACS Applied Materials & Interfaces. 14(24). 27623–27633. 25 indexed citations
9.
Lv, Lingyan, et al.. (2021). HDAC6 Is Involved in the Histone Deacetylation of In Vitro Maturation Oocytes and the Reprogramming of Nuclear Transplantation in Pig. Reproductive Sciences. 28(9). 2630–2640. 15 indexed citations
10.
Lv, Lingyan, Xinrui Li, Wei Qian, et al.. (2020). Enhanced Anti-Glioma Efficacy by Borneol Combined With CGKRK-Modified Paclitaxel Self-Assembled Redox-Sensitive Nanoparticles. Frontiers in Pharmacology. 11. 558–558. 21 indexed citations
11.
Lv, Lingyan, Tong Feng, Saif ur Rehman, et al.. (2020). Valproic acid enhances in vitro developmental competence of porcine handmade cloned embryos. Livestock Science. 233. 103957–103957. 1 indexed citations
12.
Dai, Guoliang, et al.. (2019). Celastrol inhibits colorectal cancer through TGF-β1/Smad signaling. OncoTargets and Therapy. Volume 12. 509–518. 38 indexed citations
13.
Wang, Xiuzhen, Lingyan Lv, Junjie Fu, et al.. (2017). Glioma and microenvironment dual targeted nanocarrier for improved antiglioblastoma efficacy. Drug Delivery. 24(1). 1401–1409. 36 indexed citations
14.
Zhao, Yue, Yan Jiang, Wei Lv, et al.. (2016). Dual targeted nanocarrier for brain ischemic stroke treatment. Journal of Controlled Release. 233. 64–71. 127 indexed citations
15.
Jiang, Yan, Lingyan Lv, Huihui Shi, et al.. (2016). PEGylated Polyamidoamine dendrimer conjugated with tumor homing peptide as a potential targeted delivery system for glioma. Colloids and Surfaces B Biointerfaces. 147. 242–249. 57 indexed citations
16.
Lv, Lingyan, Yan Jiang, Xin Liu, et al.. (2016). Enhanced Antiglioblastoma Efficacy of Neovasculature and Glioma Cells Dual Targeted Nanoparticles. Molecular Pharmaceutics. 13(10). 3506–3517. 26 indexed citations
17.
Wang, Zhongyuan, Yue Zhao, Yan Jiang, et al.. (2015). Enhanced anti-ischemic stroke of ZL006 by T7-conjugated PEGylated liposomes drug delivery system. Scientific Reports. 5(1). 12651–12651. 102 indexed citations
18.
Wang, Baoyan, Lingyan Lv, Zhi Wang, et al.. (2015). Improved anti-glioblastoma efficacy by IL-13Rα2 mediated copolymer nanoparticles loaded with paclitaxel. Scientific Reports. 5(1). 16589–16589. 53 indexed citations
19.
Wang, Zhongyuan, Lin Wu, Ming Xu, et al.. (2015). Enhanced Neuroprotection of Ischemic Stroke Based on Liposomal Drug Delivery System Loading a Novel Uncoupler of Ischemia-induced nNOSPSD- 95. Current Signal Transduction Therapy. 10(2). 95–103. 4 indexed citations
20.
Lv, Lingyan, Zhongyuan Wang, Yue Zhao, et al.. (2014). Nanoparticles functionalized with Pep-1 as potential glioma targeting delivery system via interleukin 13 receptor α2-mediated endocytosis. Biomaterials. 35(22). 5897–5907. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ann T. Chen Breakdown of academic impact, for papers by Chunhui Ruan Breakdown of academic impact, for papers by Yibin Wang Breakdown of academic impact, for papers by Jianpei Xu Breakdown of academic impact, for papers by Deyu Miao Breakdown of academic impact, for papers by Saejeong Kim Breakdown of academic impact, for papers by Xingye Feng Breakdown of academic impact, for papers by Shunping Han Breakdown of academic impact, for papers by L. Tiffany Lyle Breakdown of academic impact, for papers by Lisha Liu
Rankless by CCL
2026